All-Oral Therapy Promising in Higher-Risk MDS, CMML

(MedPage Today) -- An all-oral combination therapy appeared to show promising activity for patients with higher-risk myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML), with acceptable safety, according to results from a...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news